Latham & Watkins LLP advises industry-leading healthcare and pharmaceutical companies on a complex range of transactions and corporate matters. These include acquisitions of specialised biotech companies and healthcare retailers, medical and pharmaceutical market entries for global clients, and start-up financing rounds and share sales for venture capital and private equity funds. Furthermore, the practice has also acted in regulatory proceedings. Leading a dedicated team that also offers legal expertise in tax, competition, employment and IP law, Henning Schneider is a healthcare and life sciences transactional specialist, and he is joined on a diverse range of corporate law matters by Christoph Engeler and Henrietta Ditzen. Another leading name is Deniz Tschammler, who leads on novel platform and business management establishment matters for life science technology companies.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘Latham & Watkins’ healthcare regulatory and technology team possesses an exceptional blend of regulatory depth, commercial insight, and forward-thinking approach to innovation. I’ve had the opportunity to work closely with Deniz Tschammler and team. What sets them apart is not just their legal excellence, but their ability to partner with clients at the cutting edge of healthcare transformation. They have the ability to navigate the intersection of healthcare, life sciences, and emerging technology.’
- ‘Deniz Tschammler combines deep regulatory knowledge with commercial pragmatism and helped us think through complex EU AI and medical device regulations to develop an actionable strategy. His counsel is both technically precise and strategically grounded.’
- ‘The LW team is a great resource when it comes to work in the healthcare sector as it is deeply plugged into current developments and regulatory trends. They combine substantial experience from work in the healthcare sector, excellent commercial understanding of value chains besides best in class legal knowledge. The quality of work product is excellent. Personal interaction is highly professional and very collaborative - the team has a great "lets solve the problem" attitude.’
- ‘Henning Schneider is an outstanding healthcare lawyer in Germany. He is very well connected to numerous stakeholders across the healthcare services, medtech and pharma subsectors. The combination of comprehensive legal experience, strong understanding of business models, focus on what really matters and advice to the point make him stand out from the market.’
- ‘The team stands out through its highly efficient delivery, deep expertise, and a collaborative, solution-oriented working style. Clients benefit not only from the team’s strong legal capabilities, but also from the consistently smooth and professional cooperation. Compared to other firms, the practice combines technical excellence with a pragmatic and personable approach, making it a trusted and effective partner.’
- ‘Deniz Tschammler stands out as a fantastic partner - highly competent, efficient, and a pleasure to work with. What truly sets him apart is the rare and valuable combination of deep expertise in both medical device regulation and data privacy. This intersection is particularly critical for the development and commercialisation of digital medical products, and Deniz’s guidance has been instrumental in navigating these complex areas.’
Key clients
- Amalgam Rx
- Cheplapharm
- Demant A/S
- Dentsply Sirona
- DHL
- Flink SE
- IK Investment Partners
- Myonex
- Novo Holdings A/S
- Novo Nordisk
- Servier Monde
- SHL Telemedizin
Work highlights
Advised Demant A/S on the €700m acquisition of KIND Group.
Advised Cheplapharm on the acquisition of the worldwide commercialisation rights, excluding South Korea, for Zyprexa from Eli Lilly and Company.
Advised Novo Nordisk on the €1bn acquisition of Cardior Pharmaceuticals.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Henrietta Ditzen
Practice head
Henning Schneider; Christoph Engeler; Deniz Tschammler
Other key lawyers
Henrietta Ditzen